Westermarck, Jukka
Åbo Akademi University · University of Turku
33 papers on CoChatORCID 0000-0001-7478-3018
Most cited papers
- Verified
CIP2A increases self-renewal and is linked to Myc in neural progenitor cells
Kerosuo, L., Fox, H., Perälä, N., Ahlqvist, K., Suomalainen, A., Westermarck, J., Sariola, H., & Wartiovaara, K. (2010) · Differentiation
Neurogenesis and neuroplasticity mechanismsDevelopmental Biology and Gene Regulation
Cited by 35
- Verified
CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits
Shentu, Y.-P., Hu, W.-T., Zhang, Q., Huo, Y., Liang, J.-W., Liuyang, Z.-Y., Zhou, H., Wei, H., Ke, D., Wang, X.-C., et al. (2019) · Neurobiology of Aging
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 21
- Verified
CIP2A promotes T-cell activation and immune response to Listeria monocytogenes infection
Côme, C., Cvrljevic, A., Khan, M. M., Treise, I., Adler, T., Aguilar-Pimentel, J. A., Au-Yeung, B., Sittig, E., Laajala, T. D., Chen, Y., et al. (2016) · PLoS ONE
T-cell and B-cell ImmunologySignaling Pathways in Disease
Cited by 20
- Verified
Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias
Mäkelä, E., Pavic, K., Varila, T., Salmenniemi, U., Löyttyniemi, E., Nagelli, S. G., Ammunét, T., Kähäri, V.-M., Clark, R. E., Elo, L. L., et al. (2021) · Clinical Cancer Research
Chronic Myeloid Leukemia TreatmentsRNA Research and Splicing
Cited by 18
- Verified
Good Guy in Bad Company: How STRNs Convert PP2A into an Oncoprotein
Kurppa, K. J., & Westermarck, J. (2020) · Cancer Cell
Hippo pathway signaling and YAP/TAZProtein Tyrosine Phosphatases
Cited by 12
- Verified
SHARPIN S146 phosphorylation mediates ARP2/3 interaction, cancer cell invasion and metastasis
Butt, U., Khan, M. H., Pouwels, J., & Westermarck, J. (2022) · Journal of Cell Science
Protein Kinase Regulation and GTPase SignalingCellular Mechanics and Interactions
Cited by 6
- Verified
SHARPIN serine 146 phosphorylation mediates ARP2/3 interaction, cancer cell invasion and metastasis
Butt, U., Khan, M. H., Pouwels, J., & Westermarck, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory)
Protein Kinase Regulation and GTPase SignalingCellular Mechanics and Interactions
Cited by 6
- Verified
Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246–Sensitive Disease Subtype
Cvrljevic, A. N., Butt, U., Huhtinen, K., Grönroos, T. J., Böckelman, C., Lassus, H., Butzow, R., Haglund, C., Kaipio, K., Arsiola, T., et al. (2022) · Molecular Cancer Therapeutics
Ovarian cancer diagnosis and treatmentCancer Mechanisms and Therapy
Cited by 5
- Verified
Ovarian cancers with low CIP2A tumor expression constitute an APR-246 sensitive disease subtype
Cvrljevic, A. N., Butt, U., Huhtinen, K., Grönroos, T. J., Böckelman, C., Lassus, H., Kaipio, K., Arsiola, T., Laajala, T. D., Connolly, D. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory)
Ovarian cancer diagnosis and treatmentCancer Mechanisms and Therapy
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free